KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023)

Ginkgo Bioworks Holdings' Raw Materials history spans 3 years, with the latest figure at $905000.0 for Q2 2023.

  • For Q2 2023, Raw Materials rose 4.87% year-over-year to $905000.0; the TTM value through Jun 2023 reached $905000.0, up 4.87%, while the annual FY2022 figure was $1.6 million, 2384.38% up from the prior year.
  • Raw Materials reached $905000.0 in Q2 2023 per DNA's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $2.3 million in Q1 2023 to a low of $64000.0 in Q4 2021.
  • Average Raw Materials over 3 years is $1.1 million, with a median of $884000.0 recorded in 2022.
  • Peak YoY movement for Raw Materials: skyrocketed 2384.38% in 2022, then grew 4.87% in 2023.
  • A 3-year view of Raw Materials shows it stood at $64000.0 in 2021, then surged by 2384.38% to $1.6 million in 2022, then plummeted by 43.08% to $905000.0 in 2023.
  • Per Business Quant, the three most recent readings for DNA's Raw Materials are $905000.0 (Q2 2023), $2.3 million (Q1 2023), and $1.6 million (Q4 2022).